Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Founder of the awards Sir Leonard Blavatnik said "We are incredibly proud to elevate these select scientists to an international stage that will enable them to be recognised globally, prepare them to become world-class leaders in their scientific fields, and propel the wheel of innovation and societal progress."

Professor Eleanor Stride, Statutory Professor of Biomaterials in the Departments of Engineering Science and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), has been announced as a Finalist in the 2020 Blavatnik Awards for Young Scientists in the United Kingdom by the Blavatnik Family Foundation and New York Academy of Sciences. The awards are the largest unrestricted cash prizes available to scientists under the age of 42.

A jury of leading scientists from across the UK selected one Laureate and two Finalists in each of three categories – Life Sciences, Chemistry and Physical Sciences & Engineering. The awards are given to scientists recognised for their innovative discoveries and advances in these areas which are already changing science and our understanding of the world, despite being still in the early stages of their careers.

Professor Stride is using microbubble technology to design better ways of delivering powerful drugs directly to where they are needed without damaging other parts of the body. She says, "My research looks at several different challenges, all related to improving the delivery of drugs to specific sites in the body. The first is trying to understand the barriers that exist in tissue that prevent drugs from reaching their target. Second, is studying how those can be overcome, for example by generating localised flow or breaking down physical barriers. Third is designing drug delivery vehicles in the form or micro and nanoparticles that can be activated from outside the body to get the drugs across those tissue barriers. To do this we have had to develop not only the delivery vehicles but also new techniques for studying them and their interactions with tissue – for example using new types of fluorescence microscopy and high speed imaging".

The Blavatnik Award winners are selected by a distinguished jury of leading senior scientists and engineers from throughout the UK. The New York Academy of Sciences' Chief Scientific Officer, Scientific Programs and Awards, Dr. Brooke Grindlinger, explains what captured the jury's attention about Professor Stride's research. "As a leader in the field of microbubble bioengineering, Professor Eleanor Stride is pushing the boundary of what we think is possible in clinical translational research. From the development of microbubbles as drug delivery vessels and their directed use as therapy for disease, to the creation of startup companies and public engagement, Professor Stride is a bold, young innovator improving lives and inspiring minds."

Professor Stride says of her award, "It is a huge honour to receive the Blavatnik award both for me personally but much more importantly for our research group as a whole. It is very valuable, particularly for translational research, to have this sort of international recognition; and for an engineering team to receive a Life Sciences award is really exciting".

Professor Stride, along with the other 2020 Laureates and Finalists, will be honoured at a black-tie gala dinner and ceremony at Banqueting House in London on 4th March 2020. The following day, the honourees will present their research with a series of short, interactive lectures at a public symposium, "Game Changers: 9 Young Scientists Transforming Our World". The event is free and open to the public. 

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.